enGene Therapeutics Inc. (ENGNW) Capital expenditures 2022–2025
enGene Therapeutics Inc. (ENGNW) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$1.5MFY2025 · since FY2022: $153,000 → $1.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $1.5M | +60.5% |
| FY2024 | $925,000 | +190.9% |
| FY2023 | $318,000 | +107.8% |
| FY2022 | $153,000 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice
More ENGNW financial trends
ENGNW RevenueENGNW Net incomeENGNW Net marginENGNW Gross profitENGNW Gross marginENGNW Operating incomeENGNW Operating marginENGNW Operating cash flowENGNW Free cash flowENGNW Return on equityENGNW Stock buybacksENGNW Dividends paidENGNW Total assetsENGNW Total liabilitiesENGNW Shareholders’ equityENGNW overview →